BrightFocus Editorial Staff
This research was supported by BrightFocus
BrightFocus Foundation, a Maryland nonprofit, has announced the awarding of research grants to three scientists at Johns Hopkins University. The grantees’ research topics reflect the three diseases of aging that the foundation is working to end: Alzheimer’s, glaucoma, and macular degeneration.
Resham Chhabra, PhD, received a grant for $100,000 for her research on Alzheimer’s disease. Fengquan Zhou, PhD, received a $150,000 grant for his research on glaucoma, made possible in part by a bequest from the Timothy Miles Charitable Trust. Michael Paulaitis, PhD, of the Wilmer Eye Institute at Johns Hopkins, received a grant award of $160,000 for his research on macular degeneration.
Since 1983, BrightFocus has awarded research grants to 57 Johns Hopkins scientists, for a total of more than $6.8 million in funding.
“BrightFocus has a record going back decades of funding outstanding Johns Hopkins scientists like Drs. Chhabra, Zhou, and Paulaitis,” says Diane Bovenkamp, PhD, BrightFocus Vice President, Scientific Affairs. “We are proud to help support these and other top researchers pursuing game-changing ideas on prevention, treatment, and cures of Alzheimer’s, glaucoma, and macular degeneration.”
BrightFocus recently announced $13.3 million in new grants in the fight against the devastating conditions we all fear most: loss of sight and loss of mind. The current BrightFocus portfolio of 177 projects spans the globe and is guided by world-class scientific review committees.
To learn more, please visit https://www.brightfocus.org/research
BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Through its flagship research programs — Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research— the Foundation has awarded nearly $300 million in groundbreaking research funding over the past 51 years and shares the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.
Disclaimer: The information provided here is a public service of BrightFocus Foundation and is not intended to constitute medical advice. Please consult your physician for personalized medical, dietary, and/or exercise advice. Any medications or supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical products or therapies.
BrightFocus proudly supports over 200 cutting-edge research grants, fueling the global fight against Alzheimer’s disease, macular degeneration, and glaucoma.
BrightFocus Foundation’s 2024 annual report highlights groundbreaking research and public awareness efforts over the last year to defeat Alzheimer’s disease, macular degeneration, and glaucoma.
Global brain and vision research nonprofit BrightFocus Foundation has appointed three industry leaders to its board of directors.
BrightFocus Foundation hosted its inaugural Concert for Cures on Wednesday, June 26, at City Winery in Nashville.
